NCT02288104

Brief Summary

This study is a prospective study in order to demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure in two main indications: Kidneys and liver. This innovative study will involve the use of probe-based confocal laser endomicroscopy. The proposed study is a feasibility study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2014

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 11, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 17, 2017

Completed
Last Updated

August 29, 2017

Status Verified

August 1, 2017

Enrollment Period

2.2 years

First QC Date

October 27, 2014

Last Update Submit

August 28, 2017

Conditions

Keywords

Interventional RadiologyLiverKidneyConfocal endomicroscopyOptical BiopsyScannerFluoroscopyCTComputed TomographyRadiofrequency AblationFluorescein

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy (sensitivity specificity) of endomicroscopy as compared to histopathology

    Assessment of the accuracy of Cellvizio confocal mini probe imaging guided by fluoroscopy at the tumor boundary compared with traditional histopathology from physical biopsies

    up to 2 weeks

Secondary Outcomes (4)

  • Measure adverse events frequency in the use of mini probes on the tumor

    Up to 1 week

  • Classification of endomicroscopy images from benign and malignant conditions

    Up to 6 months

  • Percentage of biopsies guided by nCLE (needle-based Confocal Laser Endomicroscopy) which provide a definitive diagnosis as a measure of efficiency of endomicroscopy-targeted biopsies compared to traditional needle biopsies

    Up to 5 months

  • Number of patients for whom endomicroscopy could have affected the clinical workflow

    Up to 5 months

Study Arms (1)

needle based confocal endomicroscopy

OTHER

The patient, scheduled for a standard liver or kidney percutaneous biopsy or ablation will undergo a needle-based confocal laser endomicroscopy procedure during the procedure. The objectives of this study are to demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure and determine whether it is technically feasible to obtain images from Cellvizio during an interventional radiology procedure.

Device: needle based confocal endomicroscopy

Interventions

real time imaging of living tissue at microscopic scale, through a needle.

needle based confocal endomicroscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled to have an interventional radiology procedure for needle-biopsy or radiofrequency ablation purposes in liver or Kidney.
  • Only subjects who have provided written informed consent for the study can be included in the study.

You may not qualify if:

  • Patients have a known allergy to fluorescein
  • Patient is Pregnant or breast-feeding
  • Patient under judiciary control
  • Patient under the tutelage of a guardian
  • Patient unable to sign the information consent form (in case of an emergency situation or difficulty in understanding the information)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nouvel Hôpital Civil

Strasbourg, 67091, France

Location

Study Officials

  • Afshin Gangi

    NHC, Strasbourg, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2014

First Posted

November 11, 2014

Study Start

January 1, 2015

Primary Completion

March 17, 2017

Study Completion

March 17, 2017

Last Updated

August 29, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations